The aim of this study is to determine whether and to which extent pentosidine (PEN) is influenced in the case of advanced osteoarthritis (OA) in urine and in some tissues. Reverse phase HPLC method for PEN determination with fluorescence monitoring was utilized. Urinary pentosidine (U-PEN) and pyridinoline (U-PD) were determined in the group (N=67, age 67.1+/-11.7 years) in patients with OA before and after surgery (knee or hip replacement), and in healthy age-matched controls (N=18, age 67.0+/-6.0 years). Cartilage, synovial membrane and granulation tissue were also treated. In OA group significantly higher (P<0.001) U-PEN concentrations before (7.5+/-5.1 nmol/mmol creat.) and after (4.9+/-2.6 nmol/mmol creat.) surgery were found. U-PD was not significantly different between the groups (62.5+/-33.0 and 55.0+/-29.51 nmol/mmol creat., respectively), but differed significantly (P<0.0002 and P<0.01) from healthy subjects (40.2+/-16.5 nmol/mmol creat.). In the newly formed granulation tissue, PEN concentrations are significantly lower than in cartilage and in synovial tissues.

Institute of Rheumatology Na Slupi 4 128 50 Prague Czech Republic

See more in PubMed

Arthritis Rheum. 1994 May;37(5):724-8 PubMed

Br J Rheumatol. 1997 Jun;36(6):637-42 PubMed

J Rheumatol. 1998 Dec;25(12 ):2440-4 PubMed

J Biol Chem. 1989 Dec 25;264(36):21597-602 PubMed

Anal Biochem. 1997 Nov 1;253(1):26-32 PubMed

Diabetes. 1997 Sep;46 Suppl 2:S19-25 PubMed

Rheumatology (Oxford). 1999 Dec;38(12 ):1275-8 PubMed

Biochem Biophys Res Commun. 1998 Mar 6;244(1):45-9 PubMed

FASEB J. 2000 Jan;14(1):145-56 PubMed

Biol Pharm Bull. 1998 Oct;21(10 ):1005-8 PubMed

Arthritis Rheum. 2001 Nov;44(11):2562-71 PubMed

Pentosidine, an advanced glycation end-product, may reflect clinical and morphological features of hand osteoarthritis